As shown in Figure 7A,B, the findings of MTT assay suggested that compared with the miR-27a inhibitors + siRNA-NC group, the proliferation rate of GC cells in the miR-27a inhibitors + SFRP1-siRNA group was significantly faster (P < 0.05). Here, SFRP1 is linked to gastric cancer.